FDA’s Second-Guessing Of Device Applications Spurs Public Citizen Protest

Public Citizen cites FDA's vacillations over Cyberonics' VNS Therapy as the source of its concern with the device as a possible treatment for depression

More from Archive

More from Medtech Insight